Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

Pulmonx Insiders Sell 78,340 Shares — 2dPulmonx insiders across multiple roles—CEO Glendon French III, General Counsel David Lehman, Chief Commercial Officer Rose Geoffrey Beran, Chief Science & Technology Officer Radhakrishnan Srikanth, and a prior insider Geoffrey Rose—each sold sizable portions of LUNG stock on September 1, 2026 around $2.26 per share, trimming their holdings but leaving them with substantial positions and pointing to tax-withholding-driven transactions disclosed in SEC filings. The sales followed a period of solid quarterly results and a generally favorable analyst sentiment surrounding Pulmonx, with a mid-$2 price and upside targets noted by analysts.